First Time Loading...

Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013

Watchlist Manager
Dr Sulaiman Al-Habib Medical Services Group Co Logo
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Watchlist
Price: 297.2 SAR 2.55% Market Closed
Updated: May 19, 2024
Section:
 

Relative Value

The Relative Value of one Dr Sulaiman Al-Habib Medical Services Group Co stock under the Base Case scenario is 331.36 SAR. Compared to the current market price of 297.2 SAR, Dr Sulaiman Al-Habib Medical Services Group Co is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
331.36 SAR
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.7
P/S
P/S
Price to Sales
10.7
vs History
15
vs Industry
13
Median 3Y
9.3
Median 5Y
8.7
Industry
2.4
Forward
8.6
More Details
49.4
P/E
P/E
Price to Earnings
49.4
vs History
26
vs Industry
10
Median 3Y
47.6
Median 5Y
44.9
Industry
24.1
Forward
44.4
More Details
31.6
P/OCF
P/OCF
Price to OCF
31.6
vs History
21
vs Industry
13
Median 3Y
29.4
Median 5Y
27.1
Industry
16
More Details
123.3
P/FCFE
P/FCFE
Price to FCFE
123.3
vs History
3
vs Industry
5
Median 3Y
48.9
Median 5Y
42.7
Industry
23.1
More Details
15.7
P/B
P/B
Price to Book Value
15.7
vs History
15
vs Industry
4
Median 3Y
13.1
Median 5Y
11.9
Industry
2.3
More Details
11
EV/S
EV/S
Enterprise Value to Sales
11
vs History
15
vs Industry
12
Median 3Y
9.3
Median 5Y
8.8
Industry
2.5
Forward
8.9
More Details
31.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
31.9
vs History
17
vs Industry
7
Median 3Y
28.4
Median 5Y
26.8
Industry
5.3
More Details
43.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
43.6
vs History
15
vs Industry
6
Median 3Y
38.5
Median 5Y
35.6
Industry
13.1
Forward
36.4
More Details
50.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
50.1
vs History
17
vs Industry
7
Median 3Y
46.1
Median 5Y
43.2
Industry
17.8
Forward
45.3
More Details
32.6
EV/OCF
EV/OCF
Enterprise Value to OCF
32.6
vs History
19
vs Industry
13
Median 3Y
29.9
Median 5Y
27.5
Industry
15.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
62
Median 5Y
51.3
Industry
19.7
More Details
8.4
EV/IC
EV/IC
Enterprise Value to IC
8.4
vs History
44
vs Industry
11
Median 3Y
8.7
Median 5Y
8.3
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Dr Sulaiman Al-Habib Medical Services Group Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
104B SAR 10.7 49.4 43.6 50.1
US
HCA Healthcare Inc
NYSE:HCA
85.4B USD 1.3 15.6 9.4 12.4
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
119.4B CNY 5.8 34.3 22.7 22.7
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
15.5B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
15.6B Zac 0 0 0 0
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
70.1B BRL 1.5 34.4 10.3 13.2
TH
Bangkok Dusit Medical Services PCL
SET:BDMS
464.8B THB 4.6 32.3 19 24.9
US
Tenet Healthcare Corp
NYSE:THC
12.5B USD 0.6 4.8 6 7.7
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 14.6 8.9 12.9
MY
IHH Healthcare Bhd
KLSE:IHH
55.2B MYR 2.6 18.7 10.7 14.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
857.2B INR 5.4 112.1 43.9 62.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.